to study the effects of enzyme induction on its pharmacokinetics , a single oral dose of the new antiarrhythmic agent mexiletine hydrochloride 400 mg was administered to 8 healthy volunteers before and after treatment with rifampicin 300 mg b.i.d . for ten days .
C0003195
antiarrhythmic agent
C0543459
mexiletine hydrochloride